The stock value of Aclarion, Inc. (NASDAQ: ACON) surged by 90.15% to $6.37 as of the most recent premarket session. This increase follows a strategic alliance that might greatly increase the company’s power and reach in the healthcare industry.
Introducing Nociscan to Southern California
Aclarion has signed a business contract with San Diego, California-based Scripps Health, a preeminent healthcare organization. A significant milestone for the firm will be reached when Aclarion’s Nociscan technology is brought to the area under the terms of this agreement.
Patients, especially those looking for relief from persistent low back pain, will now have access to Nociscan from Scripps Health, which is known for being the biggest healthcare provider in San Diego. Scripps Green Hospital will provide Nociscan, giving patients access to improved diagnostic tools and more precise treatment planning.
Resolving Prolonged Low Back Pain with Creative Approaches
Approximately 266 million individuals worldwide suffer from chronic low back pain (cLBP), making it a serious global health concern. The innovative, non-invasive Nociscan technology from ACON stands out as a reaction to this. It uses a Software-as-a-Service (SaaS) paradigm to assist doctors in differentiating between lumbar spine discs that cause pain and those that don’t.
Nociscan provides doctors with crucial information that can direct treatment decisions by scientifically quantifying chemical biomarkers associated with disc pain. Nociscan provides priceless insights that can enhance patient outcomes when combined with other diagnostic techniques.
The Contribution of Scripps Health to Improving Spine Care
Over half a million patients are treated each year by Scripps Health, a nonprofit healthcare organization that includes five hospitals and 19 outpatient clinics. Nociscan will be included into clinical practice and current research studies by the system, which is known for being a pioneer in clinical research and teaching.
This effort is being led by Scripps orthopedic physician Dr. Robert Eastlack. The system will be able to provide millions of Southern Californians with enhanced diagnostic alternatives thanks to his experience and his substantial contributions to the field of spine care research, which will further advance the field of spine care.